CODI: Enhancing machine learning-based molecular profiling through contextual out-of-distribution integration

Molecular analytics increasingly utilize machine learning (ML) for predictive modeling based on data acquired through molecular profiling technologies. However, developing robust models that accurately capture physiological phenotypes is challenged by the dynamics inherent to biological systems, variability stemming from analytical procedures, and the resource-intensive nature of obtaining sufficiently representative datasets. Here, we propose and evaluate a new method: Contextual Out-of-Distribution Integration (CODI). Based on experimental observations, CODI generates synthetic data that integrate unrepresented sources of variation encountered in real-world applications into a given molecular fingerprint dataset. By augmenting a dataset with out-of-distribution variance, CODI enables an ML model to better generalize to samples beyond the seed training data, reducing the need for extensive experimental data collection. Using three independent longitudinal clinical studies and a case-control study, we demonstrate CODI's application to several classification tasks involving vibrational spectroscopy of human blood. We showcase our approach's ability to enable personalized fingerprinting for multiyear longitudinal molecular monitoring and enhance the robustness of trained ML models for improved disease detection. Our comparative analyses reveal that incorporating CODI into the classification workflow consistently leads to increased robustness against data variability and improved predictive accuracy.

Authors

Institutions

Publication Details

Journal
PNAS Nexus
Published
2024-10-01
DOI
https://doi.org/10.1093/pnasnexus/pgae449
Citations
5
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CODI: Enhancing machine learning-based molecular profiling through contextual out-of-distribution integration

Mihaela Žigman, Frank Fleischmann, Barbara Obermayer‐Pietsch, Marinus Huber et al.
5 citations
PNAS Nexus
Computational Drug Discovery Methods
1.81
article

CODI: Enhancing machine learning-based molecular profiling through contextual out-of-distribution integration

Mihaela Žigman, Frank Fleischmann, Barbara Obermayer‐Pietsch, Marinus Huber, Tarek Eissa, Annette Peters, Birgit Linkohr
article en
5 citations

Abstract

Molecular analytics increasingly utilize machine learning (ML) for predictive modeling based on data acquired through molecular profiling technologies. However, developing robust models that accurately capture physiological phenotypes is challenged by the dynamics inherent to biological systems, variability stemming from analytical procedures, and the resource-intensive nature of obtaining sufficiently representative datasets. Here, we propose and evaluate a new method: Contextual Out-of-Distribution Integration (CODI). Based on experimental observations, CODI generates synthetic data that integrate unrepresented sources of variation encountered in real-world applications into a given molecular fingerprint dataset. By augmenting a dataset with out-of-distribution variance, CODI enables an ML model to better generalize to samples beyond the seed training data, reducing the need for extensive experimental data collection. Using three independent longitudinal clinical studies and a case-control study, we demonstrate CODI's application to several classification tasks involving vibrational spectroscopy of human blood. We showcase our approach's ability to enable personalized fingerprinting for multiyear longitudinal molecular monitoring and enhance the robustness of trained ML models for improved disease detection. Our comparative analyses reveal that incorporating CODI into the classification workflow consistently leads to increased robustness against data variability and improved predictive accuracy.

PNAS NexusVol. 3(10)
Zimmer Biomet (Netherlands) (NL), Helmholtz Zentrum München (DE), Max Planck Institute of Quantum Optics (DE), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE)
Austrian Federal Ministry of Economy, Family and Youth, Bundesministerium für Bildung und Forschung, Bundesministerium für Verkehr, Innovation und Technologie, Ludwig-Maximilians-Universität München, Steirische Wirtschaftsförderungsgesellschaft, Centre for Advanced Laser Applications, Helmholtz Zentrum München
Openalex Percentile: Top 13%
Computational Drug Discovery Methods
1.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.